Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 887-891

  Ergen, Arzu ^a   İsbir, Selim ^b   Timirci, Özlem ^a   Tekeli, Atike ^c   Isbir, Turgay ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c Uskudar State Hospital   (Turkey)

^d YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Lipids; Oxidant; Polymorphism; Risk

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

EID: 79951579677     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0181-4     Document Type: Article

References (32)

1. SJ Klebanoff AM Waltersdorph H Rosen 1984 Antimicrobial activity of myeloperoxidase Methods Enzymol 105 399 403 1:CAS:528:DyaL2cXksFaqsbg%3D 10.1016/S0076-6879(84)05055-2 6328193 (Pubitemid 14165406)
2. R Zhang Z Shen WM Nauseef SL Hazen 2002 Defects in leukocytemediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase- deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma Blood 99 1802 1810 1:CAS:528: DC%2BD38XhvFyqu70%3D 11861298 (Pubitemid 34533056)
3. R Zhang ML Brennan Z Shen JC MacPherson D Schmitt CE Molenda SL Hazen 2002 Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation J Biol Chem 277 46116 46122 1:CAS:528:DC%2BD38XovFKiur8%3D 10.1074/jbc.M209124200 12359714 (Pubitemid 35417600)
4. S Sugiyama Y Okada GK Sukhova R Virmani JW Heinecke P Libby 2001 Macrophage myeloperoxidase regulation by macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am J Pathol 158 879 891 1:CAS:528:DC%2BD3MXitlOnurY%3D 11238037 (Pubitemid 32221781)
5. R Zhang ML Brennan X Fu RJ Aviles GL Pearce MS Penn EJ Topol DL Sprecher SL Hazen 2001 Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2136 2142 1:CAS:528:DC%2BD3MXot1Wqu78%3D 10.1001/jama.286.17.2136 11694155 (Pubitemid 34041599)
6. SJ Klebanoff 1980 Oxygen metabolism and the toxic properties of phagocytes Ann Intern Med 93 480 489 1:CAS:528:DyaL3cXlvVCjtL4%3D 6254418 (Pubitemid 10055919)
7. HM Abu-Soud SL Hazen 2000 Nitric oxide is a physiological substrate for mammalian peroxidases J Biol Chem 275 37524 37532 1:CAS:528:DC%2BD3cXoslWgsbs%3D 10.1074/jbc.275.48.37524 11090610 (Pubitemid 32004861)
8. JP Eiserich S Baldus ML Brennan W Ma C Zhang A Tousson L Castro AJ Lusis WM Nauseef CR White BA Freeman 2002 Myeloperoxidase, a leukocyte-derived vascular NO oxidase Science 296 2391 2394 1:CAS:528:DC%2BD38XltFWlu7Y%3D 10.1126/science.1106830 12089442 (Pubitemid 34734213)
9. X Fu SY Kassim WC Parks JW Heinecke 2001 Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Biol Chem 276 41279 41287 1:STN:280:DC%2BD3Mnks12mtQ%3D%3D 10.1074/jbc.M106958200 11533038
10. EA Podrez D Schmidt HF Hoff SL Hazen 1999 Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro J Clin Invest 103 1547 1560 1:CAS:528:DyaK1MXjvVSntb4%3D 10.1172/JCI5549 10359564
11. EA Podrez E Poliakov Z Shen R Zhang Y Deng M Sun PJ Finton L Shan M Febbraio DP Hajjar RL Silverstein HF Hoff RG Salomon SL Hazen 2002 A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions J Biol Chem 277 38517 38523 1:CAS:528:DC%2BD38Xns1CnsbY%3D 10.1074/jbc.M205924200 12145296 (Pubitemid 35154710)
12. D Schmitt Z Shen R Zhang SM Colles W Wu RG Salomon Y Chen GM Chisolm SL Hazen 1999 Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum Biochem 38 16904 16915 1:CAS:528:DyaK1MXnslSltr4%3D 10.1021/bi991623w (Pubitemid 30013697)
13. F Shabani J McNeil L Tippett 1998 The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCl) is suppressed by anti-rheumatic drugs Free Radic Res 28 115 123 1:CAS:528:DyaK1cXjvFemtbc%3D 10.3109/10715769809065797 9645388 (Pubitemid 28288697)
14. FJ Piedrafita RB Molander G Vansant EA Orlova M Pfahl WF Reynolds 1996 An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element J Biol Chem 271 14412 14420 1:CAS:528:DyaK28Xjs1OiurY%3D 10.1074/jbc.271.24.14412 8662930 (Pubitemid 26190340)
15. A Hoy D Tregouet B Leininger-Muller O Poirier M Maurice C Sass G Siest L Tiret S Visvikis 2001 Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms Eur J Hum Genet 9 780 786 1:CAS:528:DC%2BD3MXpt1eitL8%3D 10.1038/sj.ejhg.5200702 11781690 (Pubitemid 33014591)
16. B Nikpoor G Turecki C Fournier P Theroux GA Rouleau 2001 A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians Am Heart J 142 336 339 1:CAS:528:DC%2BD3MXmsV2lu70%3D 10.1067/mhj.2001.116769 11479475 (Pubitemid 32706293)
17. R Pecoits-Filho P Stenvinkel A Marchlewska O Heimburger P Bárány CM Hoff CJ Holmes M Suliman B Lindholm M Schalling L Nordfors 2003 A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients Kidney Int 84 S172 S176 1:CAS:528:DC%2BD3sXjslCrsLs%3D 10.1046/j.1523-1755.63.s84.32.x
18. WT Friedewald RI Levy DS Fredrickson 1972 Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 499 508 1:CAS:528:DyaE38Xkslagsbw%3D 4337382
19. SA Miller DD Dykes HS Polesky 1988 Simples salting-out procedure for extracting DNA from human nucleated cells Nucleic Acid Res 16 3 1215 1:CAS:528:DyaL1cXhsVKlsrs%3D 10.1093/nar/16.3.1215 3344216
20. M Roncaglioni L Santoro B D'Avanzo E Negri A Nobili A Ledda F Pietropaolo MG Franzosi C La Vecchia GA Feruglio A Maseri 1992 On behalf of GISSI-EFRIM Investigators. The role of family history in patients with myocardial infarction: an Italian case-control study. GISSI-EFRIM Investigators Circulation 85 2065 2072 1:STN:280:DyaK383nsVGgtw%3D%3D 1591825
21. F Cambon 1999 Genetic prediction of myocardial infarction Blood Coagul Fibrinol 10 S23 S24 10.1097/00001721-199907000-00003
22. Karaali ZE, Sozen S, Yurdum M, Cacina C, Toptas B, Gok O, Agachan B (2010) Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep Feb 25. [Epub ahead of print]
23. C Zhong Z Luzhan M Genshan W Jiahong Z Xiaoli Q Qi 2010 Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease Mol Biol Rep 37 1 7 12 10.1007/s11033-009-9479-5 19247801
24. Chen LL, Zhu TB, Yin H, Huang J, Wang LS, Cao KJ, Yang ZJ (2009) Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Mol Biol Rep Nov 12. [Epub ahead of print]
25. D Pasalić N Marinković B Grsković G Ferencak R Bernat A Stavljenić-Rukavina 2009 C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease Mol Biol Rep 36 4 775 780 10.1007/s11033-008-9244-1 18401567
26. JJ Tang MW Wang EZ Jia JJ Yan QM Wang J Zhu ZJ Yang X Lu LS Wang 2010 The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study Mol Biol Rep 37 1 405 410 1:CAS:528:DC%2BC3cXisFWjtA%3D%3D 10.1007/s11033-009-9877-8 19823950
27. AC Carr MR McCall B Frei 2001 Oxidation of LDL by myeloperoxidase and reactive nitrogen species Arterioscler Thromb Vasc Biol 20 1716 1723
28. FW Asselbergs WF Reynolds JW Cohen-Tervaert GAJ Jessurun 2004 Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease Am J Med 116 429 430 1:CAS:528:DC%2BD2cXhvFaltL0%3D 10.1016/j.amjmed.2003.10.025 15006595 (Pubitemid 38299491)
29. A Stefanescua S Braun G Ndrepepa T Kopara H Pavaci J Mehilli A Schömig A Kastrati 2008 Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease Am Heart J 155 356 360 10.1016/j.ahj.2007.10.017
30. G Ndrepepa S Braun J Mehilli N von Beckerath A Schömig A Kastrati 2008 Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 2 90 96 1:CAS:528: DC%2BD1cXjsVeqsLw%3D 10.1111/j.1365-2362.2007.01908.x 18226042 (Pubitemid 351143413)
31. O DuzguncInar B Yavuz T Hazirolan 2008 Plasma myeloperoxidase is related to the severity of coronary artery disease Acta Cardiol 63 2 147 152 10.2143/AC.63.2.2029520 18468192 (Pubitemid 351548698)
32. D Lau S Baldus 2006 Myeloperoxidase and its contributory role in inflammatory vascular disease Pharmacol Ther 111 16 26 1:CAS:528: DC%2BD28XltVektrk%3D 10.1016/j.pharmthera.2005.06.023 16476484 (Pubitemid 43765542)